Meeting Abstract
COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily
Fecha
2013Autor
Ziemssen, T
Bajenaru, O
Carra, A
de Klippel, N
de Sa, J
Edland, A
Frederiksen, J
Heinzlef, O
Karageorgiou, K
Landtblom, AM
Islas, MM
Tubridy, N
Gilgun-Sherki, Y